Skip to content

Study of Meniscal Allografts

The Clinical and Medico-economical Evaluation of Meniscal Allografts in the Sequelae of Total or Sub-total Meniscectomy.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01059409
Acronym
ERAM
Enrollment
23
Registered
2010-01-29
Start date
2010-09-30
Completion date
2019-09-30
Last updated
2020-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meniscectomy Sequelae

Keywords

Meniscal Allografts, Osteoarthritis

Brief summary

Total or subtotal meniscectomies in young patients are currently responsible of pain and limitation of activities. There isn't any other treatment than meniscal replacement. But there is no randomized clinical trial on meniscal allograft to validate the efficiency of this treatment.

Detailed description

Meniscal allograft is done through United States and Europe since the last fifteen years. Operative technique has regularly improved, especially because of new arthroscopic devices. The meniscal allografts to be used are taken from dead donors and then frozen according to all the reglementary aspects of tissue bank. The graft has to be ordered as soon as the patient is randomized ; the sizing of the graft ordered is important depending on the gender size and height of the patient and on the measures of the tibial plateau on X Rays. The arthroscopic procedure is done under general or loco-regional anesthesia. The graft has to be prepared with bone blocks attached to the anterior and posterior horn of the meniscal graft. These bone blocks will be fixed through bone tunnels and the meniscus itself will be sutured on the peripheral meniscus synovial rim.

Interventions

Meniscal Allograft

Sponsors

Ministry of Health, France
CollaboratorOTHER_GOV
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age from 18 on * Previous total or subtotal meniscectomy * Medical insurance * Female patients have to be under contraceptive treatment * Sign consent form

Exclusion criteria

* Age \< 18 years * Pregnant or breast-feeding woman * Need of a simultaneous frontal osteotomy * Inflammatory disease * Septic background * Psychiatric background * Understanding difficulties or problems for follow-up * No consent * No medical insurance

Design outcomes

Primary

MeasureTime frameDescription
Function Subscale in the Koos Scale (area under the curve)2 years follow upKoos Scale

Secondary

MeasureTime frameDescription
Clinical criteria: pain, quality of life, professional activityAt 2 years follow-upPain, quality of life, professional activity
Post operative and late complicationsAt 2 years follow-upPost operative complications

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026